Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2012-08-31 01:30Life Technologies and Sino Biological Form Proteomics Partnership and more...
2012-08-30 01:30New Beijing Facility for MicroConstants China Given GLP Cert
2012-08-29 01:30CompanDX, a UK Biomarker Startup, Raises $6.1 Million from China and more...
2012-08-28 01:30China to Grant India Greater Access to its Pharma Market
2012-08-26 01:30The Week in Review: Joincare to Invest $157 Million for Antibiotic Facility
2012-08-25 01:30New Essential Drug List Now Expected to Include 700 Drugs
2012-08-24 01:30Golden Meditech to Distribute Cord Blood Processing Device in China and more...
2012-08-23 01:30FortuneRock Given Go-Ahead to Begin China Trials of Long-Acting Interferon and more...
2012-08-22 01:30Biostar Moves Closer to Launching Topical Pain Relief Product and more...
2012-08-21 01:30CNBG Institute Buys Vaccine Conjugate Technology from FinaBio
2012-08-19 01:30The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs
2012-08-18 01:30Tigermed Completes $80 Million IPO on the ChiNext Exchange and more...
2012-08-17 01:30Irish University Sets Up Collaboration with China Organizations
2012-08-16 01:30Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen
2012-08-15 01:30WuXi PharmaTech Reports 29% Rise in Q2 Revenues
2012-08-14 01:30Cipla Focuses its China Investment, Emphasizes Biosimilars and more...
2012-08-12 01:30Week in Review: Singapore's S*BIO Sells Cancer Drug to US Pharma
2012-08-11 01:30S*BIO of Singapore Sells Cancer Drug Rights to MEI Pharma
2012-08-10 01:30Takeda Opens China Clinical Trial Center in Shanghai
2012-08-09 01:30Biostar Pharma Says Gelatin Scandal Will Cut Q2 Revenues in Half
2012-08-08 01:30Mindray Medical Beats Estimates with Strong Q2 Report
2012-08-07 01:30PharmaEngine Acquires China Rights to Nanobiotix Cancer Product
2012-08-05 01:30The Week in Review: Tigermed, clinical CRO, Plans IPO - FLASH: Pricing set
2012-08-04 01:30Barclays Upgrades Outlook on Companies in China Healthcare Sector
2012-08-03 01:30Covidien Invests $45 Million into China Technology Center and more...
2012-08-02 01:30Kinex Pharma of the US Receives Investment from Hong Kong Investor
2012-08-01 01:30Tigermed, a China Clinical Stage CRO, Schedules ChiNext IPO

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC